Longitudinal assessment of high versus low levels of fractional exhaled nitric oxide among children with asthma and atopy

dc.date.accessioned2022-01-04T20:31:44Z
dc.date.accessioned2022-10-25T18:48:01Z
dc.date.available2022-01-04T20:31:44Z
dc.date.available2022-10-25T18:48:01Z
dc.date.created2022-01-04T20:31:44Z
dc.date.issued2014
dc.identifierhttps://hdl.handle.net/20.500.12866/10595
dc.identifierLung
dc.identifierhttps://doi.org/10.1007/s00408-013-9551-8
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4785086
dc.description.abstractFractional exhaled nitric oxide (FeNO) has emerged as an important biomarker in asthma. Increasing evidence points to atopy as a confounding factor in the interpretation of elevated FeNO. We conducted a longitudinal study to understand the clinical significance of FeNO as an inflammatory biomarker.
dc.languageeng
dc.publisherSpringer Verlag
dc.relationurn:issn:1432-1750
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAsthma
dc.subjectAtopy
dc.subjectInflammation
dc.subjectExhaled nitric oxide
dc.titleLongitudinal assessment of high versus low levels of fractional exhaled nitric oxide among children with asthma and atopy
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución